Goldyne Savad Institute of Gene Therapy
Head of the lab
Promoting research into promising new therapies and speeding
The Goldyne Savad Institute of Gene Therapy (GTI) mission is to promote research into promising new therapies and accelerate the translation of discoveries from the bench to the bedside. GTI leverages its extensive preclinical expertise and state-of-the-art facilities to promote product development by biotechnology companies. The research focus of the unit revolves mainly around the role of chemokines and chemokine receptors in stem cell mobilization, inflammation, and cancer.
Assets
- ~75 scientists and supporting personnel
- 500m2 of newly renovated lab space at the Hadassah MC
- Competent GMP facility having already produced over 50 first-in-man products
- Vast experience in molecular cellular and animal models
- Deep understanding in product development and clinical trial design
Areas of expertise
• Hematopoietic stem cell biology
• NK cell biology
• Novel CAR-T cells
• Immunotherapy of cancer
• Development of novel HTP screen for
identification of novel anti-cancer agents
• Unique preclinical models for cancer, inflammation and immunity
Among our clients
- BIOLINE RX
- GAMIDA CELL
- KAHR MEDICAL
- BIOKINE
- AYALA PHARMACEUTICALS
- CELLECT
